Molina Healthcare Enters Material Agreement, Files 8-K

TL;DR

Molina Healthcare just signed a big deal and filed an 8-K. Watch this space.

AI Summary

On August 12, 2025, Molina Healthcare, Inc. entered into a material definitive agreement, likely related to financing, as indicated by the filing of a Form 8-K. This filing also confirms the creation of a direct financial obligation or an off-balance sheet arrangement for the registrant. The company is based in Long Beach, California.

Why It Matters

This filing signals a significant financial event for Molina Healthcare, potentially impacting its debt structure, operational capacity, or strategic initiatives.

Risk Assessment

Risk Level: medium — Material definitive agreements and financial obligations can introduce new risks or alter existing ones for a company.

Key Players & Entities

• MOLINA HEALTHCARE, INC. (company) — Registrant
• August 12, 2025 (date) — Date of earliest event reported
• 200 Oceangate, Suite 100, Long Beach, California 90802 (address) — Principal executive offices

FAQ

Key Financial Figures

• $0.001 — ge on which registered Common Stock , $0.001 Par Value MOH New York Stock Exchang
• $500 m — ent in an aggregate principal amount of $500 million, with a Delayed Draw A-2 Maturity

Filing Documents

• moh20250811_8k.htm (8-K) — 29KB
• ex_851405.htm (EX-10.1) — 1092KB
• 0001437749-25-026208.txt ( ) — 1446KB
• moh-20250812.xsd (EX-101.SCH) — 3KB
• moh-20250812_def.xml (EX-101.DEF) — 12KB
• moh-20250812_lab.xml (EX-101.LAB) — 15KB
• moh-20250812_pre.xml (EX-101.PRE) — 12KB
• moh20250811_8k_htm.xml (XML) — 3KB

01. Entry into a Material Definitive Agreement to Partially Fund a Stock Repurchase Program

Item 1.01. Entry into a Material Definitive Agreement to Partially Fund a Stock Repurchase Program. On August 12, 2025, Molina Healthcare, Inc. (the "Company") entered into a Fourth Amendment to its Credit Agreement (the "Amended Credit Agreement") among the Company, as the Borrower, the Lenders (as defined therein), and Truist Bank, as Administrative Agent, Issuing Bank and Swingline Lender. The Amended Credit Agreement amends and restates the Company's prior Credit Agreement dated as of June 8, 2020 (as amended prior to August 12, 2025, the "Prior Credit Agreement"). The terms of the Amended Credit Agreement are substantially similar to the terms of the Prior Credit Agreement, but with an additional Delayed Draw A-2 Commitment under the Amended Credit Agreement in an aggregate principal amount of $500 million, with a Delayed Draw A-2 Maturity Date of August 12, 2027 (the "Term Loan A-2"). Loans under the Term Loan A-2 are subject to an applicable margin of 0.50% for base rate loans and 1.50% for SOFR-based loans. The Company intends to use the Term Loan A-2 proceeds to partially fund its previously authorized stock repurchase program as a temporary measure due to the timing of subsidiary dividends to the parent company later this year. The foregoing description of the Amended Credit Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Amended Credit Agreement attached hereto as Exhibit 10.1 and incorporated herein by reference. Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 10.1* Fourth Amendment to Credit Agreement, dated as of August 12, 2025, by and among the Company, the Lenders party thereto and Truist Bank, as Administrative Agent, Issuing Bank and Swingline Lender. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). * Certain schedules (or similar attachments) to this exhibit have been omitted pursuant to Regulation S-K, Item 601(a)(5). The registrant agrees to furnish a copy of any omitted schedule (or similar attachment) to the Securities and Exchange Commission upon request. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MOLINA HEALTHCARE, INC. Date: August 12, 2025 By: /s/ Jeff D. Barlow Jeff D. Barlow Chief Legal Officer and Secretary

View Full Filing

View this 8-K filing on SEC EDGAR